McKesson (MCK) – Reuters
-
McKesson to buy pharma tech firm Rx Savings for up to $875 million
-
Drug distributor McKesson seen getting likely boost from COVID vaccine demand
-
Washington state, in $95 billion opioid trial, blames drug distributors for crisis
-
New York, drug distributors reach $1.18 billion opioid settlement as national deal looms
-
N.Y. jury urged to hold drugmakers liable for U.S. opioid crisis
-
McKesson begins distribution of Johnson & Johnson's COVID-19 vaccine
-
Amazon launches online pharmacy in new contest with drug retail
-
McKesson says states seek $21 billion from drug distributors in opioid settlement
-
Trump Administration picks McKesson for coronavirus vaccine distribution
-
Canadian drug distributors say no to Trump import plan
-
Several states wary of $48 billion opioid settlement proposal
-
Teva, three U.S. drug distributors reach opioid settlement - source
-
Drug distributors and Teva reach settlement in Ohio opioid litigation: WSJ
-
Drug firms offer to settle U.S. opioid suits with $50 billion package: sources
-
Wall Street slips as weak economic data offsets earnings strength
-
Trump administration proposes altering rule on drug rebates
-
Glenview's Robbins says talk of Amazon's entering pharma is overblown
-
Drug suppliers' shares rise as looming Amazon threat appears to ease
-
Amazon, Berkshire, JPMorgan partner to cut U.S. healthcare costs
-
New York City sues drug companies over opioid epidemic
-
U.S. moves to block massive health insurer deals led by Anthem, Aetna
-
Dow, S&P 500 end up in late turnaround; Alcoa dips after hours
Back to MCK Stock Lookup
